Las Vegas, NV -- (SBWIRE) -- 10/10/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Agenus Inc (NASDAQ:AGEN), Arrowhead Research Corp (NASDAQ:ARWR), EnteroMedics Inc (NASDAQ:ETRM), Baltic Trading Ltd (NYSE:BALT
Agenus Inc (NASDAQ:AGEN) managed to keep its fall at -3.64% on above-normal volume of 1.51M shares. The stock settled at $2.91 after floating in a range of $2.74 to $2.99. Its latest price has reached market capitalization of $73.63 million. Its 52-week range has been $2.45 to $5.40. Agenus Inc., including its subsidiaries, (Agenus) is a biotechnology company focused on the development and commercialization of technologies to treat cancers and infectious diseases.
Has AGEN Found The Bottom and Ready To Move Up? Find Out Here
Arrowhead Research Corp (NASDAQ:ARWR) traded up on a volume of 1.41 million, higher than its standard daily volume. Shares have gained 6.01% to $7.23. Over the last twelve months, the stock has gained 74.9% and faced a worst price of $1.65. Arrowhead Research Corporation (Arrowhead) is a nanomedicine company engaged in development therapeutic products at the interface of biology and nano-engineering to cure disease and improve human health.
For How Long ARWR’s Gloss will Attract Investors? Find out via this report
EnteroMedics Inc (NASDAQ:ETRM) settled 1.57% higher at $1.29 on above-normal volume of 1.38M shares during the last trading day. The stock has its 12-month high at $3.70 and 52-week low price was $0.81. It traded in a range of $1.23 to $1.38 during the last trading day. EnteroMedics Inc. (EnteroMedics) is a development- stage medical device company. The Company focused on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders.
Why Should Investors Buy ETRM After the Recent Fall? Just Go Here and Find Out
In the last trading session, Baltic Trading Ltd (NYSE:BALT) was down on high volume, trading at a volume of 1.36M versus its average daily volume of 1.09 million shares. At $4.72 , the stock has attained market capitalization of 166.65 million. Baltic Trading Limited conducts shipping business focused on the drybulk industry spot market. The Company was formed by Genco Shipping & Trading Limited (Genco), an international drybulk shipping company.
Why Should Investors Buy BALT After the Recent Fall? Just Go Here and Find Out
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimer at: http://www.equityobserver.com/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)